Parallel Paths, Uneven Progress: Health Care Provider and Patient Perspectives on Anti‐Amyloid Therapies for Early AD

HCPs continue to build up the knowledge and competence needed to diagnose early AD and address the complexities of integrating anti-amyloid therapy in clinical practice. P/Cs are interested in new treatments but remain concerned about access, side effects, and stigma. These findings point to critical gaps in readiness and alignment that must be addressed to support the effective adoption of available therapies.